Stay updated on Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Related Topics: Multiple Myeloma and MedlinePlus Genetics, and added the TRIMM-2 Blood 2025 publication reference; removed the earlier Blood 2025 online-ahead-of-print reference.
    Difference
    0.2%
    Check dated 2025-12-30T22:34:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New locations are listed for the study, including California, New York, North Carolina, Pennsylvania, Tennessee, Wisconsin, and also Alberta and Ontario in Canada. Locations headings for individual states/provinces were removed in favor of a consolidated Locations section, and the page revision version updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T21:39:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page shows updates to the study record dates and related metadata (e.g., Last Update Posted 2025-12-05). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T19:25:17.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page no longer lists 'Multiple myeloma' and its related topics (MedlinePlus Genetics). This reduces disease context for the study.
    Difference
    0.1%
    Check dated 2025-12-02T17:28:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Publications section description updated to indicate PubMed auto-fills publications and that listed articles may not be about the study; revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:47:46.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Administrative updates include adding the Last Update Posted (Estimated) timestamp and MedlinePlus Genetics related topics, and removing a funding-lapse notice; these changes do not modify the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:21:28.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.